Explore more publications!
Reunion Health News
Got News to Share?

Reunion Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Health News.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 12, 2026

Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
2 hours ago

Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations

Indeterminate GlobeNewswire
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
2 hours ago

Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals

Indeterminate GlobeNewswire
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company
2 hours ago

Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

Indeterminate GlobeNewswire
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG
4 hours ago

Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG

Indeterminate GlobeNewswire
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
4 hours ago

Press Release: Belén Garijo to become Chief Executive Officer of Sanofi

Indeterminate GlobeNewswire
Communiqué de presse : Belén Garijo nommée Directrice générale de Sanofi
4 hours ago

Communiqué de presse : Belén Garijo nommée Directrice générale de Sanofi

Indeterminate GlobeNewswire
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
5 hours ago

Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance

Indeterminate GlobeNewswire
Ipsen réalise de solides résultats en 2025, grâce à une performance soutenue de toutes les aires thérapeutiques, et annonce ses objectifs 2026
5 hours ago

Ipsen réalise de solides résultats en 2025, grâce à une performance soutenue de toutes les aires thérapeutiques, et annonce ses objectifs 2026

Indeterminate GlobeNewswire
BioRestorative Announces Pricing of $5.0 Million Public Offering
7 hours ago

BioRestorative Announces Pricing of $5.0 Million Public Offering

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Pricing of Underwritten Offering
8 hours ago

Xilio Therapeutics Announces Pricing of Underwritten Offering

Indeterminate GlobeNewswire
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
11 hours ago

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions